KLS-3021

N/A

Report date: 2023/03/12 17:35:27

Base Information

Drug NameKLS-3021
Drug Alias NameKLS-3021
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionCell death stimulantsGene transferenceImmunologic cytotoxicity +[4] 
TargetsProgrammed cell death protein 1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKolon Life Science. Inc
China Registration ClassN/A

Develop Information

Active CompaniesKolon Life Science. Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A